WAP-14789-30976
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 852 / AZ
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-13
- 2021-05-24
-
2021-08-22
Survey response — 6 months, dose 2MedDRA: Ageusia, Cough, Injection site pain, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Aching at the injection site, coughing, sneezing, loss of tasteMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-22 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Aching at the injection site, coughing, sneezing, loss of taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Injection site pain | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release